» Articles » PMID: 32446640

"Remote Monitoring of Intranasal Ketamine Self-Administration As Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?"

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2020 May 25
PMID 32446640
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Psychotropics and COVID-19: An analysis of safety and prophylaxis.

Javelot H, Straczek C, Meyer G, Gitahy Falcao Faria C, Weiner L, Drapier D Encephale. 2021; 47(6):564-588.

PMID: 34548153 PMC: 8410507. DOI: 10.1016/j.encep.2021.08.002.


Telehealth Use in Geriatrics Care during the COVID-19 Pandemic-A Scoping Review and Evidence Synthesis.

Doraiswamy S, Jithesh A, Mamtani R, Abraham A, Cheema S Int J Environ Res Public Health. 2021; 18(4).

PMID: 33670270 PMC: 7918552. DOI: 10.3390/ijerph18041755.


COVID-19, Aging, and Mental Health: Lessons From the First Six Months.

Vahia I Am J Geriatr Psychiatry. 2020; 28(7):691-694.

PMID: 32532653 PMC: 7274086. DOI: 10.1016/j.jagp.2020.05.029.


[Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].

Sauvaget A, Dumont R, Bukowski N, Bonnot O, Auffret R, Poulet E Encephale. 2020; 46(3S):S119-S122.

PMID: 32507557 PMC: 7271849. DOI: 10.1016/j.encep.2020.05.008.

References
1.
Carr D, Goudas L, Denman W, Brookoff D, Staats P, Brennen L . Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain. 2004; 108(1-2):17-27. DOI: 10.1016/j.pain.2003.07.001. View

2.
Short B, Fong J, Galvez V, Shelker W, Loo C . Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2017; 5(1):65-78. DOI: 10.1016/S2215-0366(17)30272-9. View

3.
Medeiros da Frota Ribeiro C, Riva-Posse P . Use of Ketamine in Elderly Patients with Treatment-Resistant Depression. Curr Psychiatry Rep. 2017; 19(12):107. DOI: 10.1007/s11920-017-0855-x. View

4.
Onder G, Rezza G, Brusaferro S . Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775-1776. DOI: 10.1001/jama.2020.4683. View